Optimising strain selection and developing a biorefinery for industrially relevant micro-algae
优化菌株选择并开发工业相关微藻的生物精炼厂
基本信息
- 批准号:2269654
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:英国
- 项目类别:Studentship
- 财政年份:2019
- 资助国家:英国
- 起止时间:2019 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Grant: BB/T50872X/1 BBRSCThe main objective of this proposal is to improve the potential for commercial-scale algal biotechnology by employing different algal biorefinery approaches. Candidate species will be selected based upon their biochemical profile and cellular characteristics, ease of cultivation, and commercialisation potential. For example, Chlorella spp., Nannochloropsis spp., Phaeodactylum sp. and Tisochyrsis sp. are all capable of synthesising an array of pigments, carotenoids and essential fatty acids that make them potentially valuable for nutrition, pharmaceutical and aquaculture feed industries. Furthermore, they all have different cell morphologies which give them varying degrees of recalcitrance to downstream processing. In order to obtain the highest value from the biomass produced, a variety of cell disruption (freeze/thawing, bead milling, sonication) and product purification (filtration, centrifugation, chromatography) techniques will be investigated. Feasibility studies can then be performed in large-scale photobioreactors to give a better overview of the commercial potential of industrial micro-algal biotechnology. Another sticking point is the lack of tailoring culture of media and conditions to the microalgal specie being exploited. This can have a major impact in terms of the quality and quantity of biomass produced. In order to address these issues the student will work closely with both the academic partner, SAMS (UHI), and the industrial partner, Xanthella, since both organisations are on the same site this will further facilitate feedback in relation to the production methods/scale and biorefinery approaches being undertaken. Specifically we will: The project a. Initially candidate micro-algal species will be selected based upon expertise, applicability/end-use, and marketability and legislature (i.e. GRAS certified)(Month 0-3). b. A suite of methods will be developed and optimised that will be used throughout the studentship to assess growth (haemocytometer/optical density/Coulter counter) and the biochemical composition of the algal biomass (spectrophotometry/HPLC/GC-MS). Optimal growing conditions for each candidate species will be determined using a high-throughput screening approach (multi-well plate reader). (Month 0-18). c. Cultivation conditions (e.g. media formulation, salinity, light and temperature regime using CT rooms, Algem environmental modelling PBR's and Xanthella's PBRs, and selective breeding) will be tested to amend cellular properties with a view to ease cell disruption and enhance product yield (Month 6-24). d.Reward The most promising candidate specie(s) will be cultivated at a larger-scale, using the microPharos and Pandora photobioreactors (PBRs), in alignment with the biorefinery framework this will completed at Xanthella Ltd premises (Month 18-36). e. Algal biomass will be disrupted using a variety of techniques (e.g. freeze-thaw/bead milling/sonication). Disruption efficiency will be assessed using both direct and indirect methods (cell counts/biochemistry/microscopy/flow cytometry coupled with human-assisted machine learning). Efforts will be made to achieve selective release during the cell destruction step to facilitate further fractionation steps. For this purpose, as specific components are located on different cell compartments or organelles, the understanding of cellular topology is required to design a selective release strategy that take advantage of this compartmentalisation (Month 6-36). f.Reward Different biorefinery strategies will be explored on a species-by-species basis. Strategies will be founded upon the previous experiences of the supervisory team and will take into account target product(s) of interest, extractability, and techno-economic analysis (Month 6-36). Supervisory Team: Professor Michele Stanley, Dr Sebastien Jubeau, Dr Valeria Montalescot and Dr Michael Ross
授予:BB/T50872 X/1 BBRSC本提案的主要目的是通过采用不同的藻类生物精炼方法来提高商业规模藻类生物技术的潜力。候选种属将根据其生化特征和细胞特征、易培养性和商业化潜力进行选择。例如,小球藻属,微拟球藻属,Phaeodactylum sp.和Tisochyrsis sp.都能够合成一系列色素、类胡萝卜素和必需脂肪酸,这使得它们对营养、制药和水产养殖饲料工业具有潜在价值。此外,它们都具有不同的细胞形态,这使它们对下游加工具有不同程度的依赖性。为了从产生的生物质中获得最高价值,将研究各种细胞破碎(冻融、珠磨、超声处理)和产物纯化(过滤、离心、色谱)技术。然后可以在大规模光生物反应器中进行可行性研究,以便更好地概述工业微藻生物技术的商业潜力。另一个症结是缺乏针对正在开发的微藻物种的培养基和条件的定制培养。这可能对所生产的生物质的质量和数量产生重大影响。为了解决这些问题,学生将与学术合作伙伴SAMS(UHI)和工业合作伙伴Xanthella密切合作,因为这两个组织都在同一地点,这将进一步促进有关生产方法/规模和生物精炼方法的反馈。具体而言,我们将:项目A。最初,将根据专业知识、适用性/最终用途、可销售性和立法(即GRAS认证)选择候选微藻物种(第0-3个月)。B.一套方法将开发和优化,将在整个学生期间使用,以评估生长(血细胞计数器/光密度/库尔特计数器)和藻类生物质的生化组成(分光光度法/HPLC/GC-MS)。将使用高通量筛选方法(多孔板读数器)确定每种候选种属的最佳生长条件。(0-18个月)。C.将测试培养条件(例如,使用CT室的培养基配方、盐度、光照和温度方案、Algem环境建模PBR和Xanthella的PBR以及选择性育种),以修改细胞特性,从而减轻细胞破坏并提高产品产量(第6-24个月)。d.奖励最有前途的候选物种将在更大规模的培养,使用microPharos和Pandora光生物反应器(PBRs),与生物精炼框架保持一致,这将在Xanthella有限公司完成(第18-36个月)。e.将使用多种技术(例如冻融/珠磨/超声处理)破坏藻类生物质。将使用直接和间接方法(细胞计数/生物化学/显微镜/流式细胞术结合人工辅助机器学习)评估破坏效率。将努力在细胞破坏步骤期间实现选择性释放,以促进进一步的分级分离步骤。为此,由于特定组分位于不同的细胞区室或细胞器上,因此需要了解细胞拓扑结构以设计利用这种区室化的选择性释放策略(第6-36个月)。f.奖励将在逐个物种的基础上探索不同的生物精炼战略。战略将建立在监督团队以前的经验基础上,并将考虑目标产品的利益,可提取性和技术经济分析(第6-36个月)。督导小组:Michele Stanley教授、Dr. Jubeau、Dr. Valeria Montalescot和Dr. Michael Ross
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
其他文献
吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('', 18)}}的其他基金
An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
- 批准号:
2901954 - 财政年份:2028
- 资助金额:
-- - 项目类别:
Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
- 批准号:
2896097 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
- 批准号:
2780268 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
- 批准号:
2908918 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
- 批准号:
2908693 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
- 批准号:
2908917 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
- 批准号:
2879438 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
- 批准号:
2890513 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
- 批准号:
2876993 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
相似国自然基金
固定化Ochrobactrum sp. strain FJ1@Fe NPs协同去除水中内分泌干扰物17-雌二醇的机制
- 批准号:2022J01649
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
Pseudomonas sp. strain JS3051分解代谢2,3-二氯硝基苯的机理研究
- 批准号:31900075
- 批准年份:2019
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
基于Rhodococcus sp. strain p52二噁英降解质粒接合转移的二噁英污染的基因强化修复机制研究
- 批准号:21876100
- 批准年份:2018
- 资助金额:66.0 万元
- 项目类别:面上项目
古菌Haloferax sp. strain D1227 通过龙胆酸分解代谢3-苯丙酸的分子机理研究
- 批准号:31570100
- 批准年份:2015
- 资助金额:63.0 万元
- 项目类别:面上项目
Alcaligenes faecalis strain NR 异养脱氮途径及其酶调控机制
- 批准号:51208534
- 批准年份:2012
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
Pannexin1通道蛋白与p38MAPK信号通路在应力刺激促进人MSC增殖成骨中的作用
- 批准号:30973071
- 批准年份:2009
- 资助金额:30.0 万元
- 项目类别:面上项目
应变玻璃合金相变机理及其特性的原子模拟与实验验证
- 批准号:50771079
- 批准年份:2007
- 资助金额:36.0 万元
- 项目类别:面上项目
相似海外基金
Evolutionarily smart vaccine strain selection for proactive vaccinology
用于主动疫苗学的进化智能疫苗株选择
- 批准号:
MR/Y004337/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
Project 2: Discovery of novel C. difficile antigens using genetic and biochemical approaches
项目2:利用遗传和生化方法发现新的艰难梭菌抗原
- 批准号:
10625693 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Epidemiology and determinants of emerging artemisinin-resistant malaria in Ethiopia
埃塞俄比亚新出现的青蒿素耐药性疟疾的流行病学和决定因素
- 批准号:
10718838 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Synthesizability-constrained expansion and multi-objective evolution of antitubercular compounds
抗结核化合物的可合成性约束扩展和多目标进化
- 批准号:
10430402 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Development of a broad spectrum teixobactin-lipopeptide hybrid for the treatment of lung infections caused by pan-drug resistant ‘superbugs’
开发广谱替克菌素-脂肽杂合体,用于治疗泛耐药“超级细菌”引起的肺部感染
- 批准号:
10650420 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Advancing Innovative Next_generation Heterologous Vaccines Against Tuberculosis
推进创新的下一代抗结核异源疫苗
- 批准号:
10439334 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Optimization and Characterization of Novel Antifungal Peptides
新型抗真菌肽的优化和表征
- 批准号:
10620239 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Discovery of Thymidylate Kinase Inhibitors for Anti-Fungal Applications
发现用于抗真菌应用的胸苷酸激酶抑制剂
- 批准号:
10553160 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Predictive fitness models for influenza vaccine strain selection
流感疫苗株选择的预测适应性模型
- 批准号:
10350139 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Optimization and Characterization of Novel Antifungal Peptides
新型抗真菌肽的优化和表征
- 批准号:
10476773 - 财政年份:2022
- 资助金额:
-- - 项目类别: